X. Xu

1558O COVID-19 vaccine in participants (ptcpts) with cancer: Subgroup analysis of efficacy/safety from a global phase III randomized trial of the BNT162b2 (tozinameran) mRNA vaccine

N. Kitchin, S. Lockhart, R. Bailey, 2021, Annals of Oncology.

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

P. Dormitzer, F. Polack, N. Kitchin, 2021, medRxiv.

[A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].

X. Xu, B. Zhou, L. Jia, 1999, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.